{"product_id":"9780792387138","title":"Side Effects of Anti-Inflammatory Drugs IV: The Proceedings of the IVth International Meeting on Side Effects of Anti-inflammatory Drugs, held in Sheffield, UK, 7–9 August 1995","description":"\u003ch1\u003eSide Effects of Anti-Inflammatory Drugs IV: The Proceedings of the IVth International Meeting on Side Effects of Anti-inflammatory Drugs, held in Sheffield, UK, 7–9 August 1995\u003c\/h1\u003e \u003ch2\u003eRainsford, K. D.\u003c\/h2\u003e \u003cp\u003eRecent concern about the adverse effects and relative risks of  anti- inflammatory therapies has been such that another meeting was  organized in the highly successful series of meetings on this topic.  Adverse effects of anti-rheumatic and anti-inflammatory drugs are of  major concern to all involved in the prescription, care and management  of rheumatic and other patients receiving these important drugs. The  IVth International Meeting on Side-Effects of Anti-Inflammatory Drugs,  held in Sheffield, UK, 7-9 August 1995, afforded a unique  opportunity to hear the latest information and views on issues  concerning the development of adverse effects from these drugs, the  management of these effects, and the development of safer therapies.  \u003cbr\u003e  In addition to discussions on the safety relative to efficacy of  established non-steroidal and steroidal anti-inflammatory drugs and  disease-modifying agents, there was detailed consideration of the  novel cyclo-oxygenase-2 selective NSAIDs which have recently been  developed and introduced to the clinic. Also, the side effects from  therapy with biologics, notably monoclonal antibodies and oral  tolerance therapies, were considered. \u003cbr\u003e  Among the other highlights in the programme were:\u003c\/p\u003e\u003cul\u003e  \u003cli\u003eClinico-epidemiological studies on the adverse effects relative  to use\/efficacy of established and new anti-rheumatic drugs.  \u003c\/li\u003e  \u003cli\u003eProcedures for reducing the gastrointestinal adverse effects.  \u003c\/li\u003e  \u003cli\u003eMechanisms and clinical significance of adverse effects in the  gastrointestinal tract, liver, kidney, articular joints, skin and  other organs from NSAIDs. \u003c\/li\u003e  \u003cli\u003eClinical status and mechanisms of  action of the newer (third generation) of NSAIDs (e.g. etodolac,  nabumetone, meloxicam). \u003c\/li\u003e  \u003cli\u003eMedico-legal aspects of adverse effects  from anti-rheumatic drugs. \u003c\/li\u003e  \u003cli\u003eThe concept of `conditional  pharmacology' or the disease-dependence of the toxicological and  pharmacological activity of the anti-inflammatory drugs.\u003c\/li\u003e  \u003c\/ul\u003e   \u003cbr\u003e  The papers in this book were selected from those presented at the  meeting. \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 1997-04-30\u003c\/p\u003e \u003cp\u003eFormat: Hardcover\u003c\/p\u003e \u003cp\u003eISBN-13: 9780792387138\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-94-011-5394-2\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 356\u003c\/p\u003e ","brand":"Springer Netherlands","offers":[{"title":"Default Title","offer_id":46312371814540,"sku":"9780792387138","price":197.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780792387138.jpg?v=1771524844","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9780792387138","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}